| Application no. and date | 15861189.7 (espacenet) (Federated) (European Patent Register), 20150501 | | Patent/reg. no. and date | DK/EP 3220909, 20200902 | | Publication date | 20170927 | | Priority no. and date | US 201414550618, 20141121, US 201414554947, 20141126, US 201414554988, 20141126, US 201414555085, 20141126, US 201514602177, 20150121, US 201514604397, 20150123, US 201514617624, 20150209, US 201514628062, 20150220 | | EP pub. no. and date |
EP 3220909 20170927 | | Effective date | | | Applicant/owner | Antecip Bioventures II LLC, 630 Fifth Avenue, Suite 2000
New York, NY 10111, US | | Applicant ref. no. | P74875DK01 | | Inventor | TABUTEAU, Herriot, 630 Fifth Avenue Suite 2000
New York, NY 10111, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/485 (2006.01) , A61P 25/02 (2006.01) , A61P 25/24 (2006.01) , A61P 25/28 (2006.01) | | Title | BUPROPION TIL MODULATION AF LÆGEMIDDELPLASMANIVEAUER AF DEXTROMETORPHAN | | Int. application no. | US2015028901 | | Int. publication no. | WO2016081027 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
